The host immune response in respiratory virus infection: balancing virus clearance and immunopathology

Seminars in Immunopathology

Volumn 38, Issue 4, 2016, Pages 471-482

  Newton, Amy H ^a   Cardani, Amber ^a   Braciale, Thomas J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Inflammatory response; Influenza; Lungs; Respiratory infection; Virus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERLEUKIN 28A; INTERLEUKIN 29; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN LAMBDA2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; ADENOVIRIDAE; B LYMPHOCYTE; BRONCHIOLITIS; BRONCHITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; CORONAVIRUS INFECTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; ENTEROVIRUS; EPITHELIUM CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LUNG ALVEOLUS MACROPHAGE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PANDEMIC INFLUENZA; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; RESPIRATORY VIRUS; REVIEW; RHINOVIRUS; SARS CORONAVIRUS; SEASONAL INFLUENZA; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS INFECTION; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNITY; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PATHOLOGY; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTION; VIROLOGY;

ADAPTIVE IMMUNITY; ANIMALS; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERFERONS; MACROPHAGES, ALVEOLAR; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; RECEPTORS, PATTERN RECOGNITION; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTIONS;

EID: 84960340398     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-016-0558-0     Document Type: Review

References (75)

1. Molinari NA et al (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25(27):5086–96
2. Herold S et al (2012) Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury. J Leukoc Biol 92(1):75–82
3. Durbin RK, Kotenko SV, Durbin JE (2013) Interferon induction and function at the mucosal surface. Immunol Rev 255(1):25–39
4. Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14(4):778–809, table of contents
5. Crouse J, Kalinke U, Oxenius A (2015) Regulation of antiviral T cell responses by type I interferons. Nat Rev Immunol 15(4):231–42
6. Coro ES, Chang WL, Baumgarth N (2006) Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol 176(7):4343–51
7. Zhou Z et al (2007) Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 81(14):7749–58
8. Okabayashi T et al (2011) Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res 160(1–2):360–6
9. Jewell NA et al (2010) Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 84(21):11515–22
10. Jones SA (2005) Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175(6):3463–8
11. Teijaro JR (2015) The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options. Curr Top Microbiol Immunol 386:3–22
12. Horiuchi T et al (2010) Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 49(7):1215–28
13. Souza LM et al (1986) Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232(4746):61–5
14. Unkel B et al (2012) Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. J Clin Invest 122(10):3652–64
15. Huang FF et al (2011) GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med 184(2):259–68
16. Shibata Y et al (2001) GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 15(4):557–67
17. Mukaida N (2000) Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72(4):391–8
18. Lindell DM, Lane TE, Lukacs NW (2008) CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy. Eur J Immunol 38(8):2168–79
19. Ichikawa A et al (2013) CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med 187(1):65–77
20. Wang W et al (2013) Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury. Cell Res 23(4):577–80
21. Griffith JW, Sokol CL, Luster AD (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32:659–702
22. Tekkanat KK et al (2002) RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease. Eur J Immunol 32(11):3276–84
23. Tyner JW et al (2005) CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med 11(11):1180–7
24. Schutte BC, McCray PB Jr (2002) [beta]-defensins in lung host defense. Annu Rev Physiol 64:709–48
25. Valenti P, Antonini G (2005) Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 62(22):2576–87
26. Zhu J et al (2002) Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111(6):867–78
27. Reinholz M, Ruzicka T, Schauber J (2012) Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Ann Dermatol 24(2):126–35
28. Vareille M et al (2011) The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev 24(1):210–29
29. Xu W et al (2006) Role of epithelial nitric oxide in airway viral infection. Free Radic Biol Med 41(1):19–28
30. Whitsett JA, Wert SE, Weaver TE (2010) Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 61:105–19
31. Hartshorn KL (2010) Role of surfactant protein A and D (SP-A and SP-D) in human antiviral host defense. Front Biosci (Schol Ed) 2:527–46
32. Arnold R, Konig W (2005) Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression. J Immunol 174(11):7359–67
33. Short KR et al (2014) Influenza virus and endothelial cells: a species specific relationship. Front Microbiol 5:653
34. Hallin GW et al (1996) Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 24(2):252–8
35. Short KR et al (2014) Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis 14(1):57–69
36. Teijaro JR et al (2011) Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146(6):980–91
37. Hussell T, Bell TJ (2014) Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol 14(2):81–93
38. Goritzka M et al (2015) Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J Exp Med 212(5):699–714
39. Pulendran B, Maddur MS (2015) Innate immune sensing and response to influenza. Curr Top Microbiol Immunol 386:23–71
40. Mocsai A (2013) Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med 210(7):1283–99
41. Kruger P et al (2015) Neutrophils: between host defence, immune modulation, and tissue injury. PLoS Pathog 11(3):e1004651
42. Snelgrove RJ et al (2006) An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol 36(6):1364–73
43. Shornick LP et al (2008) Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J Immunol 180(5):3319–28
44. Matute-Bello G et al (1997) Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 156(6):1969–77
45. Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13(3):159–75
46. Monticelli LA et al (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12(11):1045–54
47. Culley FJ (2009) Natural killer cells in infection and inflammation of the lung. Immunology 128(2):151–63
48. Jost S, Altfeld M (2013) Control of human viral infections by natural killer cells. Annu Rev Immunol 31:163–94
49. Abboud G et al (2015) Natural killer cells and innate IFN-gamma participate in host defense against respiratory vaccinia virus infection. J Virol
50. Kos FJ, Engleman EG (1996) Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell Immunol 173(1):1–6
51. Li F et al (2012) Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J Virol 86(4):2251–8
52. Kumar P et al (2013) IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol 6(1):69–82
53. Gottschalk C, Mettke E, Kurts C (2015) The role of invariant natural killer T cells in dendritic cell licensing, cross-priming, and memory CD8(+) T cell generation. Front Immunol 6:379
54. Juno JA, Keynan Y, Fowke KR (2012) Invariant NKT cells: regulation and function during viral infection. PLoS Pathog 8(8):e1002838
55. Born WK et al (2000) Role of gammadelta T cells in protecting normal airway function. Respir Res 1(3):151–8
56. Poccia F et al (2006) Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells. J Infect Dis 193(9):1244–9
57. Dodd J et al (2009) Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease. J Immunol 182(2):1174–81
58. Simonian PL et al (2010) Gammadelta T cells protect against lung fibrosis via IL-22. J Exp Med 207(10):2239–53
59. Neyt K, Lambrecht BN (2013) The role of lung dendritic cell subsets in immunity to respiratory viruses. Immunol Rev 255(1):57–67
60. Guilliams M, Lambrecht BN, Hammad H (2013) Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal Immunol 6(3):464–73
61. Braciale TJ, Sun J, Kim TS (2012) Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol 12(4):295–305
62. Smit JJ, Rudd BD, Lukacs NW (2006) Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 203(5):1153–9
63. Shi C, Pamer EG (2011) Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11(11):762–74
64. Chen J et al (2010) Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol 84(3):1289–301
65. Herati RS et al (2014) Circulating CXCR5+ PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J Immunol 193(7):3528–37
66. Alper CM et al (1996) Prechallenge antibodies: moderators of infection rate, signs, and symptoms in adults experimentally challenged with rhinovirus type 39. Laryngoscope 106(10):1298–305
67. Channappanavar R, Zhao J, Perlman S (2014) T cell-mediated immune response to respiratory coronaviruses. Immunol Res 59(1–3):118–28
68. Zhao J, Zhao J, Perlman S (2010) T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J Virol 84(18):9318–25
69. Moskophidis D, Kioussis D (1998) Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med 188(2):223–32
70. Graham BS et al (1991) Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88(3):1026–33
71. Kennedy JL et al (2012) Pathogenesis of rhinovirus infection. Curr Opin Virol 2(3):287–93
72. Taubenberger JK, Morens DM (2008) The pathology of influenza virus infections. Annu Rev Pathol 3:499–522
73. Hwang DM et al (2005) Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol 18(1):1–10
74. (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102(3):531–7
75. Josset L et al (2013) Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. MBio 4(3):e00165–13